Mosaic ImmunoEngineering (OTCMKTS:CPMV) Stock Price Down 5.2% – Here’s What Happened

Mosaic ImmunoEngineering Inc. (OTCMKTS:CPMV) fell 5.2% on Thursday . The stock traded as low as $0.6388 and last traded at $0.6388. Approximately 224 shares traded hands during trading, an increase of 1,782% from the average daily volume of 12 shares. The stock had previously closed at $0.6740.

Mosaic ImmunoEngineering Trading Down 5.2%

The stock has a market capitalization of $4.62 million, a PE ratio of -7.10 and a beta of -0.92. The stock has a 50 day moving average price of $0.66 and a 200-day moving average price of $0.60.

Mosaic ImmunoEngineering (OTCMKTS:CPMV) last posted its quarterly earnings data on Wednesday, May 20th. The company reported ($0.02) EPS for the quarter.

Mosaic ImmunoEngineering Company Profile

Mosaic ImmunoEngineering (OTCMKTS:CPMV) is a development-stage biotechnology company focused on advancing immunotherapies and vaccine candidates through its proprietary nanoparticle platform. The company leverages virus-like particles derived from the cowpea mosaic virus (CPMV) to serve as both antigen carriers and immune stimulators, aiming to enhance the magnitude and durability of immune responses. By engineering these plant-based VLPs to display target antigens or adjuvant properties, Mosaic ImmunoEngineering seeks to create differentiated candidates for oncology indications and infectious disease prevention.

Operating out of the United States, Mosaic ImmunoEngineering is currently in preclinical stages of development.